Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Despite initial responsiveness to both chemotherapy and radiotherapy, small cell lung cancer (SCLC) commonly relapses within months. Although neuroendocrine characteristics may be difficult to demonstrate in individual cases, a relevant expression of somatostatin receptors (SSTR) on the cell surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapa, Constantin, Hänscheid, Heribert, Wild, Vanessa, Pelzer, Theo, Schirbel, Andreas, Werner, Rudolf A., Droll, Sabine, Herrmann, Ken, Buck, Andreas K., Lückerath, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991436/
https://www.ncbi.nlm.nih.gov/pubmed/26936994
http://dx.doi.org/10.18632/oncotarget.7706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991436/
https://www.ncbi.nlm.nih.gov/pubmed/26936994
http://dx.doi.org/10.18632/oncotarget.7706

Ejemplares similares